{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Healthy+Female+Participants&page=5", "query": { "condition": "Healthy Female Participants", "page": 5 }, "page_size": 10 }, "pagination": { "page": 5, "page_size": 10, "total_count": 183, "total_pages": 19, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Healthy+Female+Participants&page=6&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Healthy+Female+Participants&page=4&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-08T12:05:40.823Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06942936", "title": "A Study to Investigate the Impact of Multiple Doses of Itraconazole on AZD5004 in Healthy Participants and Multiple Doses of AZD5004 on Combined Oral Ethinyl Oestradiol and Levonorgestrel in Healthy Female Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Participants" ], "interventions": [ { "name": "AZD5004", "type": "DRUG" }, { "name": "Itraconazole", "type": "DRUG" }, { "name": "EE/LNG", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 51, "start_date": "2025-05-28", "completion_date": "2026-01-28", "has_results": false, "last_update_posted_date": "2026-02-03", "last_synced_at": "2026-10-08T12:05:40.823Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06942936" }, { "nct_id": "NCT06742853", "title": "A Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of AZD0780 With Ezetimibe Combinations in Healthy Adults With Elevated LDL-C.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Dyslipidemia" ], "interventions": [ { "name": "AZD0780", "type": "DRUG" }, { "name": "Ezetimibe", "type": "DRUG" }, { "name": "Rosuvastatin", "type": "DRUG" }, { "name": "Bempedoic Acid", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 81, "start_date": "2024-12-20", "completion_date": "2025-10-29", "has_results": false, "last_update_posted_date": "2025-11-10", "last_synced_at": "2026-10-08T12:05:40.823Z", "location_count": 2, "location_summary": "Glendale, California • Brooklyn, Maryland", "locations": [ { "city": "Glendale", "state": "California" }, { "city": "Brooklyn", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06742853" }, { "nct_id": "NCT03318809", "title": "Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 986 Administered Orally to Healthy Volunteers and Participants With Severely Impaired Renal Function", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Heart Failure" ], "interventions": [ { "name": "AMG 986", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 12, "start_date": "2017-12-12", "completion_date": "2018-04-05", "has_results": true, "last_update_posted_date": "2022-06-23", "last_synced_at": "2026-10-08T12:05:40.823Z", "location_count": 4, "location_summary": "Tustin, California • Orlando, Florida • Minneapolis, Minnesota + 1 more", "locations": [ { "city": "Tustin", "state": "California" }, { "city": "Orlando", "state": "Florida" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03318809" }, { "nct_id": "NCT03642938", "title": "Exercise Dosing for Pain in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pain" ], "interventions": [ { "name": "Walking Exercise", "type": "BEHAVIORAL" }, { "name": "Control", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Duquesne University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 41, "start_date": "2015-02-11", "completion_date": "2017-06-06", "has_results": true, "last_update_posted_date": "2023-08-02", "last_synced_at": "2026-10-08T12:05:40.823Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03642938" }, { "nct_id": "NCT07231679", "title": "A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Healthy Volunteers", "Chronic Kidney Disease" ], "interventions": [ { "name": "IGT-303", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ingenia Therapeutics INC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 94, "start_date": "2025-10-30", "completion_date": "2027-04", "has_results": false, "last_update_posted_date": "2026-10-07", "last_synced_at": "2026-10-08T12:05:40.823Z", "location_count": 4, "location_summary": "Chula Vista, California • Lakeland, Florida • Statesville, North Carolina + 1 more", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "Lakeland", "state": "Florida" }, { "city": "Statesville", "state": "North Carolina" }, { "city": "Wilmington", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT07231679" }, { "nct_id": "NCT02103985", "title": "A Study of Effect of Food on the Pharmacokinetics of a Single JNJ-39823277 (TPI-1062) Dose in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "JNJ-39823277", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johnson & Johnson Pharmaceutical Research & Development, L.L.C.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 32, "start_date": "2009-05", "completion_date": "2009-06", "has_results": false, "last_update_posted_date": "2014-06-25", "last_synced_at": "2026-10-08T12:05:40.823Z", "location_count": 1, "location_summary": "Lincoln, Nebraska", "locations": [ { "city": "Lincoln", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT02103985" }, { "nct_id": "NCT06723535", "title": "A Study to Evaluate BMS-986278 in Participants With Normal Renal Function, Severe Renal Impairment, or End-Stage Renal Disease on Intermittent Hemodialysis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Kidney Failure, Chronic", "Healthy Volunteers", "Renal Impairment" ], "interventions": [ { "name": "BMS-986278", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "84 Years", "sex": "ALL", "summary": "18 Years to 84 Years" }, "enrollment_count": 27, "start_date": "2024-12-07", "completion_date": "2025-09-19", "has_results": false, "last_update_posted_date": "2025-10-14", "last_synced_at": "2026-10-08T12:05:40.823Z", "location_count": 4, "location_summary": "Miami, Florida • Orlando, Florida", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06723535" }, { "nct_id": "NCT03501069", "title": "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Single and Multiple Oral Dose of TAK-418 in Healthy Female Participants", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "TAK-418", "type": "DRUG" }, { "name": "TAK-418 Matching Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Millennium Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "FEMALE", "summary": "18 Years to 55 Years · Female only" }, "enrollment_count": 32, "start_date": "2018-05-30", "completion_date": "2018-12-26", "has_results": true, "last_update_posted_date": "2020-06-16", "last_synced_at": "2026-10-08T12:05:40.823Z", "location_count": 2, "location_summary": "Glendale, California • Salt Lake City, Utah", "locations": [ { "city": "Glendale", "state": "California" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT03501069" }, { "nct_id": "NCT05298254", "title": "A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Herpes Simplex" ], "interventions": [ { "name": "Non-adjuvanted HSV formulation 1", "type": "BIOLOGICAL" }, { "name": "Non-adjuvanted HSV formulation 2", "type": "BIOLOGICAL" }, { "name": "Non-adjuvanted HSV formulation 3", "type": "BIOLOGICAL" }, { "name": "HSV formulation 1 with adjuvant 1", "type": "BIOLOGICAL" }, { "name": "HSV formulation 2 with adjuvant 1", "type": "BIOLOGICAL" }, { "name": "HSV formulation 3 with adjuvant 1", "type": "BIOLOGICAL" }, { "name": "HSV formulation 1 with adjuvant 2", "type": "BIOLOGICAL" }, { "name": "HSV formulation 2 with adjuvant 2", "type": "BIOLOGICAL" }, { "name": "HSV formulation 3 with adjuvant 2", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" }, { "name": "HSVTI_F1", "type": "BIOLOGICAL" }, { "name": "HSVTI_F2", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 505, "start_date": "2022-03-07", "completion_date": "2025-06-12", "has_results": false, "last_update_posted_date": "2025-09-08", "last_synced_at": "2026-10-08T12:05:40.823Z", "location_count": 6, "location_summary": "Phoenix, Arizona • Wichita, Kansas • Kansas City, Missouri + 3 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Wichita", "state": "Kansas" }, { "city": "Kansas City", "state": "Missouri" }, { "city": "Rochester", "state": "New York" }, { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05298254" }, { "nct_id": "NCT06778421", "title": "Impact of OnabotulinumtoxinA (BOTOX®) on Stress", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Stress (Psychology)", "Stress", "Healthy Adult Female Participants", "Stress, Psychologic", "Stress, Psychological Cumulative", "Stress, Physiological", "Stress Response", "Stress Levels", "Stress Perception" ], "interventions": [ { "name": "Intramuscular injection", "type": "PROCEDURE" }, { "name": "OnabotulinumtoxinA (Botox®) Injections", "type": "DRUG" }, { "name": "Sodium Chloride", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER" ], "sponsor": "Center for Advanced Facial Plastic Surgery", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "18 Years to 65 Years · Female only" }, "enrollment_count": 4, "start_date": "2025-03-19", "completion_date": "2026-01-10", "has_results": false, "last_update_posted_date": "2026-04-29", "last_synced_at": "2026-10-08T12:05:40.823Z", "location_count": 1, "location_summary": "Beverly Hills, California", "locations": [ { "city": "Beverly Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06778421" } ] }